相关实验视频
Updated: Mar 12, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
36.2K
循环利尿剂的减少与心力衰竭之间的关联 跨导管大动脉置换后的再住院治疗
Koki Takegawa1,2, Koshiro Kanaoka1, Yoshitaka Iwanaga1,3
1Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center Osaka Japan.
Circulation reports
|March 11, 2026
概括
在过导管大动脉置换 (TAVR) 后减少循环利尿剂 (LD) 显著降低心力衰竭 (HF) 稳定患者的再住院率. 这一策略改善了TAVR后高频管理的结果.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
- 干预心脏病学 干预心脏病学
背景情况:
- 过导管大动脉置换 (TAVR) 改善了心力衰竭 (HF),但术后HF再住院仍然是一个问题.
- 持续使用循环利尿剂 (LD) 可能会对HF患者产生负面影响.
- 调查LD减少对TAVR后HF再入院的影响至关重要.
研究的目的:
- 评估减少循环利尿剂 (LD) 对心力衰竭 (HF) 再住院率的影响,在经过透气管大动脉置换 (TAVR) 的患者中.
- 分析LD剂量变化与TAVR后两年内HF再入院之间的关联.
主要方法:
- 使用日本国家数据库 (2014-2021) 的回顾性观察研究.
- 包括29358名首次接受TAVR的患者,90天内没有出现HF恶化.
- 将患者分为没有LD,减少LD和非减少LD组;使用治疗权重的逆概率.
主要成果:
- 与没有减少的LD组相比,减少的LD组显示HF再住院的风险明显较低 (HR 0.46;95% CI 0.41-0.51;P<0.001).
- 在29,358名符合条件的患者中,5596人属于减少LD组,4,692人属于非减少LD组.
结论:
- 循环利尿剂的减少与TAVR后稳定患者的心力衰竭再住院的减少有关.
- 这一发现表明了优化TAVR后高频率管理的潜在治疗策略.
更多相关视频
相关概念视频
Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Heart Failure V: Medical Management
455
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
455
Aortic Regurgitation III: Medical Management
530
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
530
Heart Failure VI: Adjunct Therapies
494
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Aortic Regurgitation I: Introduction
1.0K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.0K

